Navigation Links
VIA Pharmaceuticals Set to Join Russell Microcap Index
Date:6/27/2008

SAN FRANCISCO, June 27 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. (Nasdaq: VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease, will join the Russell Microcap Index when Russell Investments reconstitutes its family of U.S. indexes on June 27 after market close, according to a preliminary list of additions posted on http://www.russell.com

"We are pleased to have been selected for inclusion in this objective, market-driven index as we believe it reflects our continued progress and potential," said Lawrence K. Cohen, Ph.D., chief executive officer of VIA Pharmaceuticals.

Membership in the Russell Microcap Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. Russell determines membership for its equity indexes primarily by objective, market-capitalization rankings and style attributes.

Annual reconstitution of Russell indexes captures the 4,000 largest U.S. stocks as of the end of May, ranking them by total market capitalization to create the Russell 3000 Index and Russell Microcap. Total returns data for the Russell Microcap and other Russell Indexes is available at http://www.russell.com/Indexes/performance/daily_total_returns_us.asp.

About Russell

Russell Investments aims to improve financial security for people by providing strategic advice, world-class implementation, state-of-the-art performance benchmarks, and a range of institutional-quality investment products. With more than $213 billion in assets under management,
'/>"/>

SOURCE VIA Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Wyeth Pharmaceuticals Announces Organizational Change
2. Access Pharmaceuticals Presents New Data at International Symposium Showing Companys Angiolix(R) Monoclonal Antibody has Potential to Treat Cancer by Attacking Cancer Stem Cells
3. Keryx Biopharmaceuticals to Present at the Jefferies & Co. Healthcare Conference
4. Portola Pharmaceuticals Names William Lis Vice President of Business Development and Commercial Operations
5. Stason Pharmaceuticals, Inc. Appoints Diana Wood as Vice President, Business Development
6. Brian Levy, OD, MSc, Named Chief Operating Officer of Danube Pharmaceuticals
7. Raptor Pharmaceuticals Corp. Announces Presentation at 5th International Cystinosis Conference 2008
8. Onyx Pharmaceuticals to Present at Jefferies 2nd Annual Healthcare Conference
9. Sunesis Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference
10. Immtech Pharmaceuticals and Beijing Capital Medical University Announce Joint Venture to Provide Contract Research Services in China
11. Synovics Pharmaceuticals Announces Continued Growth of Customer Relationships

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...BLAUVELT, N.Y., Nov. 19 Dr. Mate H...tract, responds to a press release issued on Novem...an company for making false and self-serving state...es. ,, Dr. Hidvegi stated from his office in B...t research on Avemar does not apply to AveULTRA, ...
(Date:11/19/2009)..., MUNSTER, Germany, November 19 /PRNewswire/ ...filed on November 16th, 2009 Flibanserin in the,in...nesia in Parkinson,s,disease for orphan drug statu...EMEA). Levodopa-induced dyskinesia is a complicati...,s and a serious burden to some of those,affected,...
(Date:11/19/2009)..., VIENNA, Austria, November 19 /PRNewswire/ ...rogram on one product candidate at an unexpectedly... AD02 is planned to enter into,Phase II clinical t...mmediately follows the completion of two Phase I t...ny based its fast decision on the first interim,an...
(Date:11/18/2009)...s at Queen,s University Belfast are developing new...gs which will help in the fight against the threat...ecial gel pads to ,swipe, an individual or crime s...a scanning instrument that can detect the presence...er, faster decisions to be made in response to ter...
Breaking Biology Technology:American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3New technology detects chemical weapons in seconds 2
...Pink Sheets:,VXGN), WHAT: Jim Panek, CEO of Vax... provide an update on Raven,s oncology ...posed merger and plans and prospects for t... February 13, 2008, HOW: To listen to a live we...OCEO, The webcast replay will be available...
...id (Nasdaq:,CPHD) today announced that Andrew D. M...dent, Chief Financial Officer on April 14, 2008, a...ial operations and investor,relations. Mr. Miller ...icer, and replaces John Sluis, who retired from Ce...//www.newscom.com/cgi-bin/prnh/20080129/LATU101LOG...
...armaceuticals Inc.,today announced that Edward L. ... Ullrich Schwertschlag, M.D., Ph.D., chief medical...roduct development programs at,2:45 p.m. EST on We...Conference in New York City., The update will inc...didate, SF1126, a targeted PI3 kinase inhibitor cu...
Other Biology Technology:VaxGen to Present at the 10th Annual BIO CEO and Investor Conference 2VaxGen to Present at the 10th Annual BIO CEO and Investor Conference 3Cepheid Appoints Senior VP, Chief Financial Officer to Management Team 2Semafore to Present at BIO CEO & Investor Conference 2
(Date:11/19/2009)...s of the world. It is widely used for human consum...lso is considered an exemplar plant species for st...ome architecture. The authors of the research pres...scription of the B73 maize genome to probe some of...nt biology. The ten papers consider maize centrome...
(Date:11/19/2009)...ti-institutional effort co-led by three Cold Sprin...oday in publication of a landmark series of papers...ed detail the DNA sequence of maize ( Zea mays ). ...American consumers, is one of the world,s most imp...rop grown in the United States, representing $47 b...
(Date:11/19/2009)...e-FirstCall/ -- BIO-key International, Inc. (OTC B...safety and finger-based biometric identification s...eeting held today was adjourned without any action..., (Logo: http://www.newscom.com/cgi-bin/prnh/200...of the 35 million votes cast voted in favor of the...
Breaking Biology News(10 mins):PLoS Genetics 2009 maize genome collection 2PLoS Genetics 2009 maize genome collection 3PLoS Genetics 2009 maize genome collection 4Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 2Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 3Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 4BIO-key(R) Provides Update to Special Shareholder Meeting 2BIO-key(R) Provides Update to Special Shareholder Meeting 3Medicago receives regulatory approval to begin human clinical testing with its avian flu pandemic vaccine 13683 1Medicago receives regulatory approval to begin human clinical testing with its avian flu pandemic vaccine 13683 2Medicago receives regulatory approval to begin human clinical testing with its avian flu pandemic vaccine 13683 3Unlocking the bodys defenses against cancer 55267 1Unlocking the bodys defenses against cancer 55267 2Not only the gene itself its abnormal regulation can also trigger short stature 55262 1Not only the gene itself its abnormal regulation can also trigger short stature 55262 2Not only the gene itself its abnormal regulation can also trigger short stature 55262 3
...than a breath freshener it could spot head and ne...mel Cancer Center. Their new study of a mouth rin...disease holds promise for screening those at high ...., Lead investigator Joseph Califano, M.D., says h...cancer patients and 527 individuals without cancer...
...r that has not yet invaded the surrounding tissues... the tumor one step closer to metastasis, report r...udies. , Their study, published in the Dec. 30 i... these cells, although not yet invasive, could wan...n the same breast. A lack of invasion suggested a ...
...me Project and other studies linking human DNA to ...t of research producing powerful evidence of evolu...iel J. Fairbanks explores some of the many relics ...he planet in RELICS OF EDEN: THE POWERFUL EVIDENCE...95). , This book comes at a time when the clash b...
Other Biology News:'Swish-and-spit' test accurate for cancer 2Breast cancer cells have to learn to walk before they can run 2There is powerful evidence of evolution in human DNA 2
Rabbit Anti-C/EBPalpha Polyclonal Antibody, Unconjugated from Cell Signaling Technology
Mouse Anti-Kalinin Monoclonal Antibody, Unconjugated, Clone GB3 from Abcam
Rabbit Anti-Human VEZT Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Human AADAC Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents
Biology Products: